Advances in Alzheimer's Disease
Vol.4 No.2(2015), Paper ID 56995, 8
pages
DOI:10.4236/aad.2015.42005
Confirmation of the Experimentally-Proven Therapeutic Utility of Madecassoside in an Aβ1-42 Infusion Rat Model of Alzheimer’s Disease by in Silico Analyses
Abdullah Al Mamun, Michio Hashimoto, Shahdat Hossain, Masanori Katakura, Hiroyuki Arai, Osamu Shido
Department of Environmental Physiology, Shimane University Faculty of Medicine, Izumoshi, Japan
Department of Environmental Physiology, Shimane University Faculty of Medicine, Izumoshi, Japan
Laboratory of Alternative Medicine and Behavioral Neurosciences, Department of Biochemistry and Molecular Biology, Jahangirnagar University, Dhaka, Bangladesh
Department of Environmental Physiology, Shimane University Faculty of Medicine, Izumoshi, Japan
Department of Geriatrics and Gerontology, Division of Brain Sciences, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
Department of Environmental Physiology, Shimane University Faculty of Medicine, Izumoshi, Japan
Copyright © 2015 Abdullah Al Mamun, Michio Hashimoto, Shahdat Hossain, Masanori Katakura, Hiroyuki Arai, Osamu Shido et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Mamun, A. , Hashimoto, M. , Hossain, S. , Katakura, M. , Arai, H. and Shido, O. (2015) Confirmation of the Experimentally-Proven Therapeutic Utility of Madecassoside in an Aβ
1-42 Infusion Rat Model of Alzheimer’s Disease by in Silico Analyses.
Advances in Alzheimer's Disease,
4, 37-44. doi:
10.4236/aad.2015.42005.